We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+0.14%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$204M
AUM Growth
+$15.9M
Cap. Flow
+$17.5M
Cap. Flow %
8.58%
Top 10 Hldgs %
6.14%
Holding
488
New
66
Increased
245
Reduced
135
Closed
40

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$976K
2
NFLX icon
Netflix
NFLX
+$953K
3
CRWD icon
CrowdStrike
CRWD
+$952K
4
RCL icon
Royal Caribbean
RCL
+$905K
5
TJX icon
TJX Companies
TJX
+$890K

Top Sells

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$1.11M
2
LLY icon
Eli Lilly
LLY
+$937K
3
FCX icon
Freeport-McMoran
FCX
+$933K
4
ALGN icon
Align Technology
ALGN
+$933K
5
MLM icon
Martin Marietta Materials
MLM
+$930K

Sector Composition

Rank Sector Weight
1 Financials 26.66%
2 Healthcare 19.14%
3 Technology 17.16%
4 Energy 7.21%
5 Industrials 6.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DCF
176
DELISTED
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.
DCF
$595K 0.29%
67,209
+14,764
+28% +$127K
IQI icon
177
Invesco Quality Municipal Securities
IQI
$526M
$520K 0.25%
52,429
+13,957
+36% +$134K
MRCC
178
DELISTED
Monroe Capital Corp
MRCC
$508K 0.25%
66,748
+17,088
+34% +$126K
ALNY icon
179
Alnylam Pharmaceuticals
ALNY
$36.3B
$500K 0.24%
2,058
+15
+0.7% +$2.37K
BCIC
180
BCP Investment Corp
BCIC
$86.9M
$500K 0.24%
25,488
+5,899
+30% +$115K
OXSQ icon
181
Oxford Square Capital
OXSQ
$151M
$470K 0.23%
159,850
+42,254
+36% +$132K
OFS icon
182
OFS Capital
OFS
$43.8M
$452K 0.22%
50,922
+19,198
+61% +$185K
MIRM icon
183
Mirum Pharmaceuticals
MIRM
$6.89B
$422K 0.21%
12,344
+1,329
+12% +$34.8K
SRPT icon
184
Sarepta Therapeutics
SRPT
$1.66B
$416K 0.2%
2,635
-1,396
-35% -$179K
IONS icon
185
Ionis Pharmaceuticals
IONS
$9.35B
$382K 0.19%
8,009
+361
+5% +$14.8K
ARDX icon
186
Ardelyx
ARDX
$1.24B
$376K 0.18%
50,747
+35,807
+240% +$252K
TVTX icon
187
Travere Therapeutics
TVTX
$5.33B
$374K 0.18%
45,490
+1,340
+3% +$9.03K
AXSM icon
188
Axsome Therapeutics
AXSM
$12.4B
$366K 0.18%
4,542
-658
-13% -$48.7K
UTHR icon
189
United Therapeutics
UTHR
$26.3B
$365K 0.18%
1,145
-355
-24% -$94K
IRWD icon
190
Ironwood Pharmaceuticals
IRWD
$611M
$359K 0.18%
55,075
+21,798
+66% +$154K
INSM icon
191
Insmed
INSM
$23.2B
$358K 0.18%
5,344
-7,849
-59% -$304K
GILD icon
192
Gilead Sciences
GILD
$161B
$356K 0.17%
5,182
+523
+11% +$34.9K
ACAD icon
193
Acadia Pharmaceuticals
ACAD
$4.25B
$355K 0.17%
21,826
+8,247
+61% +$133K
IBRX icon
194
ImmunityBio
IBRX
$7.44B
$355K 0.17%
56,107
+34,817
+164% +$230K
AUPH icon
195
Aurinia Pharmaceuticals
AUPH
$1.97B
$352K 0.17%
61,561
+19,366
+46% +$102K
ASND icon
196
Ascendis Pharma A/S
ASND
$16.7B
$351K 0.17%
2,576
-596
-19% -$81.1K
DAWN
197
DELISTED
Day One Biopharmaceuticals
DAWN
$351K 0.17%
25,491
+19,413
+319% +$284K
TGTX icon
198
TG Therapeutics
TGTX
$8.58B
$350K 0.17%
19,651
+14,836
+308% +$237K
HALO icon
199
Halozyme
HALO
$9.72B
$348K 0.17%
6,637
-3,022
-31% -$133K
AMGN icon
200
Amgen
AMGN
$203B
$345K 0.17%
1,103
-278
-20% -$81.7K
6 7
8
9 10

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
ALS
Andrew L. Share $214M AUM 14.75% 1-Year Est. Return

Virtus ETF Advisers's Q2 2024 Portfolio in Review

As of Q2 2024, Virtus ETF Advisers held 488 positions worth $204M, up 8.5% from $188M the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.

Virtus ETF Advisers deployed $17.5M of net new capital in Q2 2024, opening 66 new positions and adding to 245 existing holdings. Its largest new stake was Qualcomm: 5,165 shares worth $1.03M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 20% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Extra Space Storage, an estimated $732K trimmed.

  • Virtus ETF Advisers's largest Q2 2024 buy was Qualcomm: 5,165 shares worth $1.03M.
  • Virtus ETF Advisers added most to EOG Resources in Q2 2024, an estimated $789K increase.
  • Virtus ETF Advisers's biggest Q2 2024 reduction was Extra Space Storage, cutting an estimated $732K.
  • Virtus ETF Advisers fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $1.11M.
  • Virtus ETF Advisers's ten largest holdings make up 6.1% of its $204M portfolio in Q2 2024.
  • Virtus ETF Advisers opened 66 new positions and closed 40 in Q2 2024.
  • Virtus ETF Advisers's portfolio value rose 8.5% quarter-over-quarter to $204M.

Based on Virtus ETF Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.